---
category: news
title: "AI-designed drug to treat deadly disease now tested on humans"
excerpt: "The first phase of clinical trials testing an AI-designed drug to treat a chronic lung disease is now underway, according to biotech startup Insilico Medicine. Using deep learning to discover new drugs is a relatively fresh development in the pharmaceutical industry,"
publishedDateTime: 2022-02-25T17:53:00Z
originalUrl: "https://www.theregister.com/2022/02/24/ai_drug_humans/"
webUrl: "https://www.theregister.com/2022/02/24/ai_drug_humans/"
ampWebUrl: "https://www.theregister.com/AMP/2022/02/24/ai_drug_humans/"
cdnAmpWebUrl: "https://www-theregister-com.cdn.ampproject.org/c/s/www.theregister.com/AMP/2022/02/24/ai_drug_humans/"
type: article
quality: 57
heat: 67
published: false

provider:
  name: theregister
  domain: theregister.com

topics:
  - AI

images:
  - url: "https://regmedia.co.uk/2022/02/24/shutterstock_chemicals.jpg"
    width: 1200
    height: 627
    isCached: true

related:
  - title: "AI-designed protein awakens silenced genes, one by one"
    excerpt: "By combining CRISPR technology with a protein designed with artificial intelligence, it is possible to awaken individual dormant genes by disabling the chemical \"off switches\" that silence them. Researchers from the University of Washington School of Medicine in Seattle describe this finding in the journal Cell Reports."
    publishedDateTime: 2022-03-01T17:52:00Z
    webUrl: "https://phys.org/news/2022-03-ai-designed-protein-awakens-silenced-genes.html"
    ampWebUrl: "https://phys.org/news/2022-03-ai-designed-protein-awakens-silenced-genes.amp"
    cdnAmpWebUrl: "https://phys-org.cdn.ampproject.org/c/s/phys.org/news/2022-03-ai-designed-protein-awakens-silenced-genes.amp"
    type: article
    provider:
      name: Phys.org
      domain: phys.org
    quality: 57
    images:
      - url: "https://scx2.b-cdn.net/gfx/news/hires/2020/1-gene.jpg"
        width: 1915
        height: 1920
        isCached: true

secured: "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;IMxxGqEXYHP80/tTGJbpUQ=="
---

